Advantage Healthcare Services and Spencer Health Solutions | September 26, 2022
Spencer Health Solutions a digital health company based in North Carolina’s Research Triangle Park, announced that Advantage Healthcare Services, a leading provider of mental health pharmacy support for the state of California, has joined its Certified Pharmacy Partner Network to offer enhanced, in-home patient services for one of its largest commercial pharmaceutical programs.
As part of the Spencer-Certified Pharmacy Partner Network, Advantage Health will work cooperatively with SHS, pharmaceutical manufacturers, payers, and healthcare systems on large-scale, post-approval monitoring sponsored by pharmaceutical companies that provide in-home support for patients living with severe and persistent behavioral health conditions.
“Our proactive approach to patient attention and care enables us to be with a patient during all aspects of their treatment and therapies. Participating in Spencer Health Solutions’ commercial pharmacy programs, and using the spencer® patient support platform, fits perfectly with our mission to work closely with a patient and their medical team to consult, observe, and intervene when the need arises for complete collaborative healthcare.”
Nevil Jhaveri, Chief Technology Officer at Advantage Healthcare Services
The spencer smart hub collects longitudinal insights from patients that can be leveraged to generate patient interventional support strategies. The smart hub is an FDA-certified Class 1 medical device that is easy to set up and use, only requiring the patient to plug it in and place a refill pack of medicines inside. The device connects to the Internet through an integrated cellular network or the user’s Wi-Fi network to quickly and securely
Alert patients to take their pre-packaged medications on a prescribed schedule
Dispense medications and document medication adherence.
Gain greater patient access with integrated, secure telehealth services within the platform
Automatically integrate data from in-home wearable, biometric devices.
“We feel fortunate to partner with Advantage and contribute to their long-standing reputation for thinking outside the box in support of their patients,” said Tom Rhoads, founder and CEO of Spencer Health Solutions. “Having spencer in patients’ homes will significantly improve health outcomes for this high-risk population that struggles with medication adherence and engagement.”
Spencer Health Solutions is exhibiting its spencer smart hub and pouch technology at the upcoming National Association of Specialty Pharmacists (NASP) 2022 Annual Meeting and Expo, and has been invited to present at the event’s Technology Day Innovation Lab on September 19th. Spencer Health Solutions invites NASP event attendees to join them for the unique one-day workshop, or to schedule a time for a personal, on-site demo.
About Advantage Healthcare Services
Advantage Healthcare Services’ core mission is to create solutions that support patients through the care continuum and aid in improving health outcomes. Based in California, Advantage specializes in crafting tailored solutions that bridge medication access and adherence impasses. With a primary focus of serving patients suffering from behavioral and mental health disorders, the company takes a consulting approach to developing sustainable solutions for the private practice sector, as well as for state- and county-funded programs. Through the utilization of an in-house data and analytics team, Advantage produces actionable reporting tools to identify at-risk patients, enabling caretakers to proactively intervene, improve health outcomes, and reduce rehospitalizations.
About Spencer Health Solutions
Spencer Health Solutions is a digital health technology provider dedicated to improving patient engagement and medication adherence for clinical trials and commercial pharmaceutical programs. Headquartered in North Carolina’s Research Triangle Park, Spencer Health Solutions’ award-winning spencer® smart hub provides near real-time monitoring of patients’ behaviors and Rx patterns that result in improved persistency, improved patient retention, and more positive health outcomes.
Veranex and Medidee Services | September 21, 2022
Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced that it has acquired Medidee, a top MedTech consultancy company headquartered in Lausanne, Switzerland. As a trusted European regulatory and quality service consultancy joining Veranex, Medidee expands and strengthens regulatory affairs, clinical development, and quality assurance services and capabilities for MedTech companies across Europe and the world. This improved ability to navigate the European Union’s Medical Device and In Vitro Diagnostic Device Regulations challenges supports truly full-service MedTech product development and commercialization.
“Our acquisition of Medidee significantly expands our European footprint while also materially expanding the scale and scope of the clinical studies we can manage. The combined organization offers offices and expertise across Europe, the U.S., and Asia, augmenting our ability to help MedTech innovators achieve FDA and CE Mark approvals and uninterrupted market access for new as well as proven medical technologies that advance patient care.”
Veranex CEO David Dockhorn
With Medidee’s 11 locations across Europe, India, and Asia-Pacific, and Veranex’s 13 locations across the U.S., Europe, and China, the company now has unprecedented reach to serve clients with a full spectrum of integrated concept-to-commercialization services — design, engineering, regulatory, quality, preclinical research, clinical development, clinical operations, commercial strategy, and market access services — all under one umbrella. Medidee is one of the Top 3 medical device consultancy service providers in Europe uniquely positioned as a leader in future key areas such as digital health, machine learning, and cybersecurity. The company also brings expertise in clinical research exclusively focused on medical devices and in vitro diagnostics.
“Medidee has a proven track record serving regulatory, clinical, and quality needs for companies of all sizes, with consulting expertise and clinical trial support in increasingly diverse therapeutic areas and technology categories across multiple geographies,” shared Medidee co-founders Kim Rochat, Philippe Etter, and Michael Maier. “With these services, coupled with the global infrastructure of Veranex, we expand expertise and resources for the benefit of our clients as well as for all EU innovative manufacturers wishing to access rapidly and efficiently the U.S. market and beyond. We look forward to providing these additional strengths and capabilities,” added the co-founders who take on new roles in the combined organization.
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time, while its comprehensive solutions unify and streamline the entire development process. Veranex is backed by Summit Partners, Accelmed, and Lauxera Capital Partners.
About Medidee Services
With sites in Switzerland, Germany, Denmark, Belgium, Spain, USA, and APAC, Medidee is a global services supplier serving companies ranging from academic startups to majors.
Medidee was established by three partners, all experts in the field of medical devices. With 50 experts in all fields necessary to ensure compliance with the most stringent requirements, Medidee provides the necessary competencies to ensure and demonstrate compliance with all key medical device regulations. Medidee expends regularly to provide the best resources and competencies and supports more than 350 manufactures all over the world.
Dialyze Direct | July 28, 2022
Dialyze Direct, the nation’s leading provider of home hemodialysis services in Skilled Nursing Facilities. announced it has partnered with CommuniCare Family of Companies, one of the nation’s largest post-acute care providers, to conduct onsite hemodialysis services at its facilities around the U.S.
Founded in 1984 on the philosophy of “Serving with Pride,” CommuniCare’s standard of excellence, which focuses on patient care and quality of life, mirrors Dialyze Direct’s mission to change the dialysis industry by pioneering customized, gentler care proven to positively impact patients’ prognoses and quality of life. Dialyze Direct’s continued growth with like-minded healthcare providers has further solidified the company’s position as the foremost home hemodialysis provider to SNFs in the United States.
“The ultimate goal of healthcare is to provide services that benefit our clients but also to ensure those services save or significantly prolong lives. As a result, we approach partnerships with the understanding that both parties share a common patient-first philosophy. We are pleased to bring our onsite dialysis offerings to CommuniCare’s facilities and join forces with a fellow provider that also views patient comfort and care as the cornerstone of their business model.”
Dialyze Direct’s Chairman and Co-Founder Henry Kauftheil
Dialyze Direct recently announced its acquisition of Chicago-based RenPro Renal Services, which provided dialysis services to patients in SNFs in Illinois, Indiana, Ohio and Kentucky. Earlier this year, the company completed its acquisition of Compass Home Dialysis, a regional SNF dialysis provider in Pennsylvania, and at the end of 2021, the company acquired Renew Dialysis, a regional SNF dialysis provider in Ohio and Virginia.
“Providing our residents with a better quality of life is what we strive for at CommuniCare,” said Ronald Wilheim, President of CommuniCare. “We are proud to partner with Dialyze Direct and that through this partnership we have another opportunity to raise the bar and innovate our level of care.”
Dialyze Direct now offers onsite dialysis services in more than 170 SNFs in Florida, Illinois, Indiana, Kentucky, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, Tennessee, Texas, Virginia, and West Virginia.
About Dialyze Direct
Founded in 2015, Dialyze Direct is a leading kidney care innovation company that seeks breakthrough solutions for patients suffering from kidney disease. With a mission to build the next generation of kidney care, Dialyze Direct leverages its leading nephrology specialists to develop new methods and technology to evolve the treatment options nephrologists have at their disposal. Dialyze Direct pioneered significant changes to the existing treatment model for dialysis patients in skilled nursing facilities (SNFs), in which many of the most medically challenging subsets of dialysis patients reside, and has grown to become the nation’s largest provider of home dialysis in the SNF setting. Dialyze Direct’s innovative staff-assisted home hemodialysis treatment model entails a gentler, personalized treatment plan comprised of meticulously crafted protocols designed to tackle the unique fluid management challenges of geriatric dialysis patients, resulting in increased overall patient health and reduced hospitalizations while substantially decreasing costs for payors. Dialyze Direct currently operates in 13 states with new operations launching soon in additional states.
About CommuniCare Health Services
CommuniCare Health Services was founded in 1984 and is headquartered in Cincinnati, Ohio. The company currently operates more than 110 healthcare and rehabilitation centers in seven states.
Our centers focus on patient-centered care plans and provide specialized programing in cardiac, pulmonology, memory care & dementia, amputee and behavioral health. Our expert physicians and nurses provide care for the most medically complex residents.